Target Name: MIR770
NCBI ID: G768222
Review Report on MIR770 Target / Biomarker Content of Review Report on MIR770 Target / Biomarker
MIR770
Other Name(s): Hsa-mir-770 | MIRN770 | MicroRNA 770 | microRNA 770 | hsa-miR-770-5p | hsa-mir-770

MIR770: A Potential Drug Target and Biomarker

MIR770, also known as Hsa-mir-770, is a protein that is expressed in various tissues of the human body, including the brain, heart, lungs, and gastrointestinal tract. It is a member of the Mir gene family, which encodes a family of transmembrane proteins that are involved in various cellular processes, including cell signaling and inflammation.

MIR770 has been identified as a potential drug target due to its unique structure and the various functions that it is involved in. One of the key reasons for its potential as a drug target is its highly expressed(2). in various tissues of the body, which suggests that it could be a useful target for drugs that are designed to modulate its activity. Additionally, its unique structure, which is characterized by a long extracellular domain and a short intracellular domain, makes it a unique protein that is both accessible and expressed in various tissues.

MIR770 is involved in various cellular processes that are important for normal cellular function. One of the key functions of MIR770 is its role in cell signaling. MIR770 is a protein that is involved in the regulation of various signaling pathways, including the TGF-β pathway. This pathway is involved in the regulation of cellular growth, differentiation, and survival, and MIR770 is a key regulator of this pathway.

In addition to its role in cell signaling, MIR770 is also involved in the regulation of inflammation. MIR770 has been shown to be involved in the regulation of various inflammatory cytokines, including TNF-伪, IL-1尾, and IL-6. These cytokines are involved in the regulation of immune and inflammatory responses, and MIR770 plays a key role in their regulation.

MIR770 has also been shown to be involved in the regulation of cellular apoptosis(6). Apoptosis is a natural process that is involved in the regulation of cellular life and death, and MIR770 is involved in its regulation. studies have shown that MIR770 can induce apoptosis in various cell types, including cancer cells. This suggests that MIR770 could be a useful target for drugs that are designed to induce apoptosis in cancer cells.

MIR770 has also been shown to be involved in the regulation of various signaling pathways that are important for cellular growth and differentiation. For example, MIR770 has been shown to be involved in the regulation of the PI3K/Akt signaling pathway. This pathway is involved in the regulation of cellular signaling and growth, and MIR770 plays a key role in its regulation.

In addition to its role in cell signaling and apoptosis, MIR770 is also involved in the regulation of inflammation. MIR770 has been shown to be involved in the regulation of various inflammatory cytokines, including TNF-伪, IL-1尾, and IL-6 ( 5). These cytokines are involved in the regulation of immune and inflammatory responses, and MIR770 plays a key role in their regulation.

MIR770 has also been shown to be involved in the regulation of various signaling pathways that are important for cellular growth and differentiation. For example, MIR770 has been shown to be involved in the regulation of the TGF-β signaling pathway. This pathway is involved in the regulation of cellular signaling and growth, and MIR770 plays a key role in its regulation.

In conclusion, MIR770 is a protein that is expressed in various tissues of the human body and is involved in a

Protein Name: MicroRNA 770

The "MIR770 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about MIR770 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

MIR7702 | MIR7703 | MIR7704 | MIR7705 | MIR7706 | MIR7843 | MIR7844 | MIR7845 | MIR7846 | MIR7847 | MIR7848 | MIR7849 | MIR7850 | MIR7851 | MIR7854 | MIR7855 | MIR7856 | MIR7974 | MIR7975 | MIR7976 | MIR7977 | MIR802 | MIR8054 | MIR8055 | MIR8059 | MIR8060 | MIR8061 | MIR8063 | MIR8064 | MIR8067 | MIR8069-1 | MIR8070 | MIR8071-1 | MIR8071-2 | MIR8072 | MIR8073 | MIR8075 | MIR8076 | MIR8078 | MIR8080 | MIR8082 | MIR8084 | MIR8085 | MIR8087 | MIR8088 | MIR8089 | MIR8485 | MIR873 | MIR874 | MIR875 | MIR876 | MIR877 | MIR885 | MIR887 | MIR888 | MIR889 | MIR890 | MIR891A | MIR891B | MIR892A | MIR892B | MIR892C | MIR9-1 | MIR9-1HG | MIR9-2 | MIR9-3 | MIR9-3HG | MIR920 | MIR921 | MIR922 | MIR924 | MIR924HG | MIR92A1 | MIR92A2 | MIR92B | MIR93 | MIR933 | MIR934 | MIR935 | MIR936 | MIR937 | MIR938 | MIR939 | MIR940 | MIR941-1 | MIR941-2 | MIR941-3 | MIR941-4 | MIR941-5 | MIR942 | MIR943 | MIR944 | MIR95 | MIR96 | MIR98 | MIR99A | MIR99AHG | MIR99B | MIRLET7 | MIRLET7A1